Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Chemours board puts CEO and 2 financial executives on leave

by Michael McCoy
March 4, 2024 | A version of this story appeared in Volume 102, Issue 7

The board of the chemical maker Chemours has put CEO Mark Newman, its chief financial officer, and its principal accounting officer on administrative leave pending the results of an internal review. Denise Dignam, president of Chemours’s titanium technologies division, is interim CEO. Included in the scope of the board’s review is examining how the firm assesses reports made to the Chemours ethics hotline. The board will also evaluate one or more “potential material weaknesses in its internal control over financial reporting,” a press release says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.